Literature DB >> 3030206

Effect of triflusal and other salicylic acid derivatives on cyclic AMP levels in rat platelets.

J García-Rafanell, J Ramis, L Gomez, J Forn.   

Abstract

The effect of triflusal, acetylsalicylic acid (ASA), and of their principal metabolites 2-hydroxy-4-trifluoromethylbenzoic acid (HTB) and salicylic acid (SA), alone or combined with dypiridamole (DIP) and/or PGE1 on cyclic AMP levels in washed rat platelets (37 degrees C, 4 min), has been determined. DIP at 0.1 mM increased cyclic AMP levels by 25%. The effect of triflusal and HTB was significant at therapeutic concentrations of triflusal (1 mM: 36% increase) and HTB (0.5 mM: 37% increase). The effect of HTB was always greater than that of triflusal. ASA, at 1 mM and 5 mM, alone or combined with PGE1 was without effect. When 1 mM triflusal was combined with 0.1 mM DIP an increased effect was obtained (95%). ASA, at the highest concentration tested (5 mM), did not modify the DIP-induced increase of cyclic AMP levels.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3030206

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  7 in total

Review 1.  Triflusal: a review of its use in cerebral infarction and myocardial infarction, and as thromboprophylaxis in atrial fibrillation.

Authors:  David Murdoch; Greg L Plosker
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Gastrointestinal safety of triflusal solution in healthy volunteers: a proof of concept endoscopic study.

Authors:  Rosa M Antonijoan; Ignasi Gich; Analia Azaro; Sergio Sainz; Joaquim Balanzó; Iñaki Izquierdo; Javier Borja; Esther Donado; Iris Blanch; Manel J Barbanoj
Journal:  Eur J Clin Pharmacol       Date:  2011-02-16       Impact factor: 2.953

Review 3.  Triflusal.

Authors:  W McNeely; K L Goa
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

4.  Effects of triflusal and its main metabolite HTB on platelet interaction with subendothelium in healthy volunteers.

Authors:  J P De La Cruz; M A Villalobos; P J García; J M Smith-Agreda; F Sánchez de la Cuesta
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

5.  Pharmacokinetics of triflusal and its main metabolite HTB in healthy subjects following a single oral dose.

Authors:  J Ramis; R Mis; J Forn; J Torrent; E Gorina; F Jané
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Oct-Dec       Impact factor: 2.441

6.  Pharmacokinetics of triflusal and its main metabolite in rats and dogs.

Authors:  J Ramis; R Mis; J Forn
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Oct-Dec       Impact factor: 2.441

7.  Effect of Triflusal on Primary Vascular Dysregulation Compared with Aspirin: A Double-Blind, Randomized, Crossover Trial.

Authors:  Sanghoon Shin; Kwang-Joon Kim; In-Jeong Cho; Geu-Ru Hong; Yangsoo Jang; Namsik Chung; Young Min Rah; Hyuk-Jae Chang
Journal:  Yonsei Med J       Date:  2015-09       Impact factor: 2.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.